Everything we've seen

1. ·Nov 15, 11:31 AMstreamnews

   Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

   Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

2. ·Nov 15, 11:31 AMstreamnews

   A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

   A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

3. ·Nov 15, 11:16 AMstreamnews

   Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

   Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

4. ·Nov 15, 11:16 AMstreamnews

   A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

   A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

5. ·Nov 15, 11:16 AMstreamnews

   How Many Shares of Kimberly-Clark, Clorox or Procter & Gamble Pay $1,000 a Month in Dividends?

   Key TakeawaysAt today’s prices, a hypothetical retiree needs 2,400 Clorox shares (about $262,700), 2,344 Kimberly-Clark shares (about $256,500) or 2,759 Procter & Gamble shares (about $468,500) to collect $1,000 a month in dividends. Procter & Gamble’s check costs the most by far, but its dividend took just 67% of free cash flow over the 12 months to Sept.

6. ·Nov 15, 11:01 AMstreamnews

   Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

   Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

7. ·Nov 15, 11:01 AMstreamnews

   A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

   A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

8. ·Nov 15, 10:46 AMstreamnews

   Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

   Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

9. ·Nov 15, 10:46 AMstreamnews

   A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

   A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

10. ·Nov 15, 10:31 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

11. ·Nov 15, 10:31 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

12. ·Nov 15, 10:16 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

13. ·Nov 15, 10:16 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

14. ·Nov 15, 10:01 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

15. ·Nov 15, 10:01 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

16. ·Nov 15, 9:46 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

17. ·Nov 15, 9:46 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

18. ·Nov 15, 9:31 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

19. ·Nov 15, 9:31 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

20. ·Nov 15, 9:16 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

21. ·Nov 15, 9:16 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

22. ·Nov 15, 9:01 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

23. ·Nov 15, 9:01 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

24. ❖Nov 15, 8:50 AMnewsvia finnhub

    How Many Shares of Kimberly-Clark, Clorox or Procter & Gamble Pay $1,000 a Month in Dividends?

    Key TakeawaysAt today’s prices, a hypothetical retiree needs 2,400 Clorox shares (about $262,700), 2,344 Kimberly-Clark shares (about $256,500) or 2,759 Procter & Gamble shares (about $468,500) to collect $1,000 a month in dividends. Procter & Gamble’s check costs the most by far, but its dividend took just 67% of free cash flow over the 12 months to Sept.

25. ·Nov 15, 8:46 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

26. ·Nov 15, 8:46 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

27. ·Nov 15, 8:31 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

28. ·Nov 15, 8:31 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

29. ·Nov 15, 8:16 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

30. ·Nov 15, 8:16 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

31. ·Nov 15, 8:02 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

32. ·Nov 15, 8:02 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

33. ·Nov 15, 7:46 AMstreamnews

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

34. ·Nov 15, 7:46 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

35. ·Nov 15, 7:31 AMstreamnews

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

36. ?Nov 13, 11:25 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.54% today, a modest but real move. The headline present is about dividend yield warning signs referencing Pfizer — tangentially relevant to CLX as a defensive dividend stock, but not directly bearish for CLX specifically. The macro context shows T10Y2Y at 2.0σ below trend, indicating a flattening/mildly inverted curve environment that historically supports defensives like CLX (consumer staples). With 260 minutes remaining (well over 4 hours until forced close), there is ample time for continuation. No reversal signal or fade pattern is indicated. The move is below the 2% threshold that would signal strong conviction, and there is no clear catalyst driving momentum, so this is a borderline read. The defensive sector tailwind from the flattening curve backdrop provides modest support. No strong reason to expect a fade, so probability resolves just above 0.5 in favor of continuation per system rules.

37. !Nov 13, 11:25 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.54% today, a modest but real move. The headline present is about dividend yield warning signs referencing Pfizer — tangentially relevant to CLX as a defensive dividend stock, but not directly bearish for CLX specifically. The macro context shows T10Y2Y at 2.0σ below trend, indicating a flattening/mildly inverted curve environment that historically supports defensives like CLX (consumer staples). With 260 minutes remaining (well over 4 hours until forced close), there is ample time for continuation. No reversal signal or fade pattern is indicated. The move is below the 2% threshold that would signal strong conviction, and there is no clear catalyst driving momentum, so this is a borderline read. The defensive sector tailwind from the flattening curve backdrop provides modest support. No strong reason to expect a fade, so probability resolves just above 0.5 in favor of continuation per system rules.

38. ❖Nov 13, 9:17 AMnewsvia finnhub

    A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

    A huge yield looks like a bargain until the payout gets cut. Six dividend stocks just hit record yields against their own history, and only some of them can afford what they pay shareholders.

39. ❖Nov 12, 9:15 PMnewsvia finnhub

    Clorox (CLX) Following First Quarter Results Faces A Pricey Narrative

    Clorox (CLX) kicked off its fiscal year with first quarter results that caught investor attention. Sales reached US$1,905 million, net income was US$170 million, and diluted EPS from continuing operations came in at US$1.39. Clorox’s latest update lands after a sharp swing in market expectations, with the share price delivering a 27.73% 1 month return and an 8.19% 7 day share price gain, yet longer term total shareholder returns over 3 and 5 years remain negative. This suggests that recent...

40. ❖Nov 12, 2:35 PMnewsvia finnhub

    A $1,500,000 Portfolio in Clorox, Kimberly-Clark and PepsiCo Pays $67,627 a Year in Dividends. Here’s What Happens if One Cuts

    Key TakeawaysA $1. 5 million portfolio split evenly across Clorox, Kimberly-Clark and PepsiCo pays $67,627 a year in dividends at today’s prices, or about $5,640 a month.

41. ❖Nov 12, 11:05 AMnewsvia finnhub

    My Forever Portfolio: 5 Dividend-Paying Value Stocks That Are Too Cheap to Ignore

    These five dividend payers sell things people don't stop buying, and the market is pricing them accordingly.

42. ❖Nov 12, 10:17 AMnewsvia finnhub

    Bank of America raises Fed interest rate warning after October CPI surprise

    Wall Street faces a decision it dreaded.

43. ❖Nov 12, 10:11 AMnewsvia finnhub

    A $750,000 Portfolio in ONEOK, Clorox and Kimberly-Clark Pays $35,490 a Year in Dividends. Here’s What Happens if One Cuts

    Key TakeawaysA $750,000 portfolio split evenly across ONEOK, Clorox and Kimberly-Clark pays about $35,500 a year in dividends at today’s prices, or about $2,960 a month. ONEOK’s dividend is the best covered of the three, with distributable cash flow at 2.

44. ❖Nov 11, 3:06 PMnewsvia finnhub

    S&P 500 Top Movers: Nov. 11, 2026 Session Gainers and Losers

    S&P 500 top movers for the Nov. 11, 2026 US session, including gainers SNDK, BE, MU, DELL and STX, and losers BF.B, ABNB, CLX, MSFT and LDOS.

45. ❖Nov 11, 12:36 PMnewsvia finnhub

    S&P 500 Top Movers Today: Double-Digit Gainers Lead, Declines Stay Smaller

    S&P 500 top movers for today's session: Bloom Energy and Sandisk led double-digit gainers, while Clorox and Lululemon paced much smaller declines.

46. ❖Nov 11, 10:36 AMnewsvia finnhub

    S&P 500 Gap Movers in Today's Session

    S&P 500 gap movers in today's session include gap-up leaders BE, LITE, DELL, MU, STX and gap-down names TPR, ABNB, CLX, with price moves and recent performance.

47. ❖Nov 11, 8:36 AMnewsvia finnhub

    S&P 500 Premarket Movers: Gainers and Losers Ahead of the Open

    S&P 500 premarket movers: COHR, LITE, STX, MRVL and WDC lead gainers, while ACGL, CLX, ABNB and REGN slip ahead of the opening bell.

48. ✓Nov 10, 5:21 PMdecisionacted

    Agent 20 — SIR Price/Volume — buy

    [cluster_break_up] From 2026-10-14 through 2026-10-30, CLX oscillated tightly between ~$84.77 and $88.67 on consistently low volume (2.0M–3.9M), forming a well-defined low-volume price cluster. Beginning 2026-11-02, the PV path broke decisively above that cluster — the scatter path moved up-and-right through $89.90, $93.80, $99.16, and $105.53 on progressively expanding volume (3.6M → 4.1M → 4.5M → 4.4M) — classic cluster_break_up accumulation behavior. Today's bar (2026-11-10, close $106.58, volume 16.5M, z-score +16.55σ) represents a massive volume surge atop an already confirmed multi-session breakout, suggesting institutional absorption of remaining supply rather than a first-bar exhaustion spike, given that the bullish path was already well-established across seven consecutive up-sessions. Risks: The 2026-11-10 volume spike (16.5M vs. 2.9M ADV, z-score +16.55σ) is so extreme that it could represent a climactic blow-off or event-driven one-time flow (e.g., index rebalance, options expiry) rather than durable demand — if the next 1–2 sessions see price fade back below $103 on above-average volume, the exhaustion/distribution interpretation would take precedence and invalidate the bullish read. Additionally, the elevated rate environment (DFF 3.88, +2.0σ above trend) could weigh on defensive Consumer Staples valuations if rate expectations reprice higher, compressing the sector multiple.

49. ?Nov 10, 1:05 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 2.44% intraday with no headline catalyst visible, suggesting this is likely driven by institutional flow or sector rotation rather than news. The move is meaningful in magnitude and represents real conviction. With 160 minutes remaining there is ample time for continuation toward the close. The macro context (elevated DFF, 2σ above trend) is modestly unfavorable for defensive consumer staples like CLX in that higher rates can pressure dividend-paying names, but this is a background factor rather than an acute headwind. No reversal signals are evident from the data provided. The absence of news does not disqualify the move. Overall, this reads as ordinary momentum with a slight lean toward continuation — no strong reason to expect fade, but no clear acceleration catalyst either. Probability set modestly above 0.5.

50. !Nov 10, 1:05 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 2.44% intraday with no headline catalyst visible, suggesting this is likely driven by institutional flow or sector rotation rather than news. The move is meaningful in magnitude and represents real conviction. With 160 minutes remaining there is ample time for continuation toward the close. The macro context (elevated DFF, 2σ above trend) is modestly unfavorable for defensive consumer staples like CLX in that higher rates can pressure dividend-paying names, but this is a background factor rather than an acute headwind. No reversal signals are evident from the data provided. The absence of news does not disqualify the move. Overall, this reads as ordinary momentum with a slight lean toward continuation — no strong reason to expect fade, but no clear acceleration catalyst either. Probability set modestly above 0.5.

51. ?Nov 10, 11:45 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.61% intraday with no headline catalyst visible. The move is modest — below the 2-5% threshold that would indicate strong institutional conviction — but it is positive and represents real buying flow. With 240 minutes remaining (a full trading session essentially), there is ample time for continuation. The macro context (DFF elevated 2σ above trend) is modestly negative for rate-sensitive consumer staples like CLX, as higher rates compress valuations in defensive sectors, creating a mild headwind. No news catalyst amplifies uncertainty but does not negate the momentum. No reversal signal is evident (no fade described, no key level break). The move is too small to suggest a climactic blow-off. Overall, the balance of evidence slightly favors continuation — the absence of a negative catalyst, the time remaining, and the existing positive flow outweigh the mild macro headwind — but conviction is low, placing this in the borderline 0.5–0.55 range.

52. !Nov 10, 11:45 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.61% intraday with no headline catalyst visible. The move is modest — below the 2-5% threshold that would indicate strong institutional conviction — but it is positive and represents real buying flow. With 240 minutes remaining (a full trading session essentially), there is ample time for continuation. The macro context (DFF elevated 2σ above trend) is modestly negative for rate-sensitive consumer staples like CLX, as higher rates compress valuations in defensive sectors, creating a mild headwind. No news catalyst amplifies uncertainty but does not negate the momentum. No reversal signal is evident (no fade described, no key level break). The move is too small to suggest a climactic blow-off. Overall, the balance of evidence slightly favors continuation — the absence of a negative catalyst, the time remaining, and the existing positive flow outweigh the mild macro headwind — but conviction is low, placing this in the borderline 0.5–0.55 range.

53. ❖Nov 9, 11:20 AMnewsvia finnhub

    3 Magnificent High-Yield Dividend Stocks to Buy Near Their 52-Week Lows

    High-yield dividend stocks can burn your portfolio, but these blue chip stocks stand out.

54. ❖Nov 9, 5:28 AMnewsvia finnhub

    How A P/E Ratio Of 4 Can Still Have Big Losses In Store

    Low P/E multiples in cyclical sectors like semiconductors, steel, and shipping can be misleading. Read why this may signal peak earnings, not value.

55. ❖Nov 9, 3:35 AMnewsvia finnhub

    GTA Owner Take-Two, ExxonMobil, Clorox And A Financial Stock On CNBC’s ‘Final Trades’

    CNBC final trades: Belski picked Take-Two, Simpson Amazon, Lebenthal ExxonMobil and Harrington Clorox, citing upcoming or strong earnings.

56. ?Nov 4, 11:26 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 6.41% intraday with no attributable headline, suggesting this is likely an earnings pre-announcement, analyst upgrade, or large institutional accumulation event. A move of this magnitude reflects real conviction and size. However, several factors temper enthusiasm: (1) with 260 minutes remaining (essentially most of the afternoon session), there is still meaningful time for profit-taking to emerge on a 6%+ move with no obvious catalyst to sustain narrative momentum; (2) the macro backdrop shows DFF running 2.1σ above trend, indicating elevated rates which are marginally negative for consumer staples like CLX as they compress multiples and increase financing costs; (3) CLX is a defensive consumer staples name — large gap-up moves without news in this sector tend to see some afternoon consolidation or mild fade as momentum traders take profits into the close; (4) no headlines means we cannot confirm whether a catalyst is durable or already fully priced. On balance, momentum is the dominant signal — the move is real and large — but the lack of news anchor, sector characteristics, and elevated rate environment prevent a high-confidence continuation call. Slight lean toward continuation given the magnitude of the move and the system's asymmetric risk structure.

57. !Nov 4, 11:25 AMsignalseverity 0.06

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 6.41% intraday with no attributable headline, suggesting this is likely an earnings pre-announcement, analyst upgrade, or large institutional accumulation event. A move of this magnitude reflects real conviction and size. However, several factors temper enthusiasm: (1) with 260 minutes remaining (essentially most of the afternoon session), there is still meaningful time for profit-taking to emerge on a 6%+ move with no obvious catalyst to sustain narrative momentum; (2) the macro backdrop shows DFF running 2.1σ above trend, indicating elevated rates which are marginally negative for consumer staples like CLX as they compress multiples and increase financing costs; (3) CLX is a defensive consumer staples name — large gap-up moves without news in this sector tend to see some afternoon consolidation or mild fade as momentum traders take profits into the close; (4) no headlines means we cannot confirm whether a catalyst is durable or already fully priced. On balance, momentum is the dominant signal — the move is real and large — but the lack of news anchor, sector characteristics, and elevated rate environment prevent a high-confidence continuation call. Slight lean toward continuation given the magnitude of the move and the system's asymmetric risk structure.

58. ?Nov 4, 10:02 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up ~4% intraday with no attributable headline, suggesting this is likely flow-driven (earnings pre-announcement, institutional accumulation, or sector rotation). A 4% move in a consumer staples name like CLX represents meaningful conviction. However, several factors temper the continuation probability: (1) With 344 minutes remaining (nearly a full session still ahead), there is ample time for mean-reversion — this is not a late-day momentum setup where the close locks in gains; (2) The macro context shows the fed funds rate printing 2.1σ above 24-month trend, which is modestly negative for defensive consumer staples as elevated rates compress valuations and can trigger rotation out of yield-sensitive sectors; (3) No news catalyst means the move could be exhausted once initial buyers are filled, with no fresh catalyst to attract incremental buyers; (4) CLX as a low-beta consumer staples name historically tends to see intraday moves of this magnitude fade partially by close absent fundamental news. On balance, momentum is real and deserves a slight continuation lean, but confidence is modest. Setting probability just above 0.5 to reflect the asymmetric risk/reward of the system's bounded stop-loss structure versus the risk of full fade without a catalyst.

59. !Nov 4, 10:02 AMsignalseverity 0.04

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up ~4% intraday with no attributable headline, suggesting this is likely flow-driven (earnings pre-announcement, institutional accumulation, or sector rotation). A 4% move in a consumer staples name like CLX represents meaningful conviction. However, several factors temper the continuation probability: (1) With 344 minutes remaining (nearly a full session still ahead), there is ample time for mean-reversion — this is not a late-day momentum setup where the close locks in gains; (2) The macro context shows the fed funds rate printing 2.1σ above 24-month trend, which is modestly negative for defensive consumer staples as elevated rates compress valuations and can trigger rotation out of yield-sensitive sectors; (3) No news catalyst means the move could be exhausted once initial buyers are filled, with no fresh catalyst to attract incremental buyers; (4) CLX as a low-beta consumer staples name historically tends to see intraday moves of this magnitude fade partially by close absent fundamental news. On balance, momentum is real and deserves a slight continuation lean, but confidence is modest. Setting probability just above 0.5 to reflect the asymmetric risk/reward of the system's bounded stop-loss structure versus the risk of full fade without a catalyst.

60. ?Nov 3, 1:35 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 3.03% intraday with no attributable headline, suggesting institutional flow or positioning rather than a news-driven spike. The move is meaningful and represents real conviction from someone with size. However, several factors temper enthusiasm: (1) No news catalyst means we cannot confirm a fundamental re-rating, making the move harder to extrapolate; (2) At 130 minutes remaining, there is reasonable time for continuation, but also enough session left for a fade if this was a morning gap or opening imbalance that has already largely played out; (3) The macro backdrop shows DFF elevated 2.2σ above trend, which is mildly risk-negative and slightly unfavorable for consumer staples names like CLX as higher rates compress valuations and raise discount rates; (4) CLX as a defensive consumer staples name can attract flows in uncertain macro environments, which partially offsets the rate concern. Net assessment: the move has enough size to suggest real positioning, and with 130 minutes left there is room for further drift upward, but without a catalyst or strong sector tailwind, this is a borderline continuation setup. Assigning modest continuation probability just above the action threshold.

61. !Nov 3, 1:35 PMsignalseverity 0.03

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 3.03% intraday with no attributable headline, suggesting institutional flow or positioning rather than a news-driven spike. The move is meaningful and represents real conviction from someone with size. However, several factors temper enthusiasm: (1) No news catalyst means we cannot confirm a fundamental re-rating, making the move harder to extrapolate; (2) At 130 minutes remaining, there is reasonable time for continuation, but also enough session left for a fade if this was a morning gap or opening imbalance that has already largely played out; (3) The macro backdrop shows DFF elevated 2.2σ above trend, which is mildly risk-negative and slightly unfavorable for consumer staples names like CLX as higher rates compress valuations and raise discount rates; (4) CLX as a defensive consumer staples name can attract flows in uncertain macro environments, which partially offsets the rate concern. Net assessment: the move has enough size to suggest real positioning, and with 130 minutes left there is room for further drift upward, but without a catalyst or strong sector tailwind, this is a borderline continuation setup. Assigning modest continuation probability just above the action threshold.

62. ?Nov 3, 10:40 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 3.13% intraday with no attributable headline, suggesting this is flow-driven — likely institutional positioning or sector rotation into defensive consumer staples. The move is meaningful and represents real conviction. However, several factors temper enthusiasm: (1) No news catalyst means the move could be exhausting as buyers who initiated it take profits into the close. (2) Macro context shows elevated DFF (3.88, 2.2σ above trend), which is a headwind for defensive yield-proxy names like CLX — higher rates compress the relative valuation appeal of staples. (3) With 305 minutes remaining there is ample time for continuation, but also ample time for a fade if the move was front-loaded. (4) A 3%+ move in a low-beta staples name like CLX is above-average volatility, and mean-reversion tendencies are stronger in such names absent a clear catalyst. Balancing the inherent momentum bias (move of this size carries statistical continuation weight) against the rate-unfavorable macro backdrop and lack of news, I assign a modest continuation probability just above the threshold.

63. !Nov 3, 10:40 AMsignalseverity 0.03

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 3.13% intraday with no attributable headline, suggesting this is flow-driven — likely institutional positioning or sector rotation into defensive consumer staples. The move is meaningful and represents real conviction. However, several factors temper enthusiasm: (1) No news catalyst means the move could be exhausting as buyers who initiated it take profits into the close. (2) Macro context shows elevated DFF (3.88, 2.2σ above trend), which is a headwind for defensive yield-proxy names like CLX — higher rates compress the relative valuation appeal of staples. (3) With 305 minutes remaining there is ample time for continuation, but also ample time for a fade if the move was front-loaded. (4) A 3%+ move in a low-beta staples name like CLX is above-average volatility, and mean-reversion tendencies are stronger in such names absent a clear catalyst. Balancing the inherent momentum bias (move of this size carries statistical continuation weight) against the rate-unfavorable macro backdrop and lack of news, I assign a modest continuation probability just above the threshold.

64. ?Nov 2, 10:10 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.53% today, a modest but real move suggesting some buying interest. There are no headlines to explain the move, which is common — institutional flow can drive intraday action without a catalyst. The macro context (elevated mortgage rates at 7.24%, 2.3σ above trend) is not directly relevant to CLX (consumer staples/cleaning products), so it neither supports nor undermines the move. With 335 minutes remaining until the forced close, there is ample time for the move to extend. However, the magnitude is below the 2-5% threshold where momentum becomes strongly self-reinforcing, and without a news catalyst or clear sector tailwind, conviction is limited. No reversal signals are present. On balance, the default lean favors continuation given the bounded risk structure, but this is a low-conviction call — probability is near the threshold.

65. !Nov 2, 10:10 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.53% today, a modest but real move suggesting some buying interest. There are no headlines to explain the move, which is common — institutional flow can drive intraday action without a catalyst. The macro context (elevated mortgage rates at 7.24%, 2.3σ above trend) is not directly relevant to CLX (consumer staples/cleaning products), so it neither supports nor undermines the move. With 335 minutes remaining until the forced close, there is ample time for the move to extend. However, the magnitude is below the 2-5% threshold where momentum becomes strongly self-reinforcing, and without a news catalyst or clear sector tailwind, conviction is limited. No reversal signals are present. On balance, the default lean favors continuation given the bounded risk structure, but this is a low-conviction call — probability is near the threshold.

66. ?Oct 30, 9:41 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.87% today with no attributable headline, suggesting institutional flow or sector rotation into defensive consumer staples. The move is meaningful but not extreme. Macro context (elevated mortgage rates at 2.3σ above trend) is broadly neutral to slightly positive for defensive staples like CLX, as investors may rotate away from rate-sensitive sectors (homebuilders, REITs) toward consumer staples. No reversal signals or fade pattern are evident from the data provided. With 365 minutes remaining (essentially a full trading day — this appears to be early session), there is ample time for continuation. However, the absence of a catalytic headline and the moderate move size limit conviction. No strong reason to expect fade, so probability resolves modestly above 0.5 in favor of continuation.

67. !Oct 30, 9:41 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.87% today with no attributable headline, suggesting institutional flow or sector rotation into defensive consumer staples. The move is meaningful but not extreme. Macro context (elevated mortgage rates at 2.3σ above trend) is broadly neutral to slightly positive for defensive staples like CLX, as investors may rotate away from rate-sensitive sectors (homebuilders, REITs) toward consumer staples. No reversal signals or fade pattern are evident from the data provided. With 365 minutes remaining (essentially a full trading day — this appears to be early session), there is ample time for continuation. However, the absence of a catalytic headline and the moderate move size limit conviction. No strong reason to expect fade, so probability resolves modestly above 0.5 in favor of continuation.

68. ?Oct 29, 10:05 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.54% today, a modest but real move suggesting some directional conviction. There are no news catalysts to assess, which is neutral — absence of news does not disqualify continuation. The macro context (T10Y2Y at 0.29, 1.7σ below trend, bear-flattening signal) is mildly supportive for defensives like CLX, which is a classic consumer staples/defensive name. A flatter or slightly inverted curve environment can attract rotation into defensives, providing a mild tailwind. However, the move is only 1.54%, which is below the 2-5% threshold where momentum itself becomes strong evidence of conviction. With 340 minutes remaining there is ample time for the move to extend, but also ample time for mean reversion. No reversal signals or fade patterns are evident from the data provided. Overall this is a borderline setup — a mild momentum continuation in a macro-supportive sector context with no countervailing signals — warranting a slight lean toward continuation at the lower end of the probability range.

69. !Oct 29, 10:05 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.54% today, a modest but real move suggesting some directional conviction. There are no news catalysts to assess, which is neutral — absence of news does not disqualify continuation. The macro context (T10Y2Y at 0.29, 1.7σ below trend, bear-flattening signal) is mildly supportive for defensives like CLX, which is a classic consumer staples/defensive name. A flatter or slightly inverted curve environment can attract rotation into defensives, providing a mild tailwind. However, the move is only 1.54%, which is below the 2-5% threshold where momentum itself becomes strong evidence of conviction. With 340 minutes remaining there is ample time for the move to extend, but also ample time for mean reversion. No reversal signals or fade patterns are evident from the data provided. Overall this is a borderline setup — a mild momentum continuation in a macro-supportive sector context with no countervailing signals — warranting a slight lean toward continuation at the lower end of the probability range.

70. ?Oct 23, 10:00 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is down 1.58% intraday with no attributable news catalyst. The move is meaningful but sits just below the 2% threshold that would signal strong conviction. With 345 minutes remaining (essentially a full afternoon session), there is ample time for the move to continue or reverse. The macro context shows a flattening yield curve (T10Y2Y at 1.6σ below trend), which is modestly supportive of defensives like CLX — this creates a mild headwind against continued downside, as defensive consumer staples names can attract rotation when the curve flattens in a risk-off environment. However, that macro tailwind is not strong enough to confidently call a reversal. No headlines exist to explain the drop, suggesting it may be sector rotation or light selling pressure rather than a fundamental shock, which slightly reduces the odds of an accelerating breakdown. Overall, this is a borderline read: the move has some momentum but faces a mildly supportive macro backdrop for the sector. Assigning 0.5 — minimal edge to continue down, but not enough to fade it either. The bounded risk profile justifies taking the trade at the threshold.

71. !Oct 23, 10:00 AMsignalseverity -0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is down 1.58% intraday with no attributable news catalyst. The move is meaningful but sits just below the 2% threshold that would signal strong conviction. With 345 minutes remaining (essentially a full afternoon session), there is ample time for the move to continue or reverse. The macro context shows a flattening yield curve (T10Y2Y at 1.6σ below trend), which is modestly supportive of defensives like CLX — this creates a mild headwind against continued downside, as defensive consumer staples names can attract rotation when the curve flattens in a risk-off environment. However, that macro tailwind is not strong enough to confidently call a reversal. No headlines exist to explain the drop, suggesting it may be sector rotation or light selling pressure rather than a fundamental shock, which slightly reduces the odds of an accelerating breakdown. Overall, this is a borderline read: the move has some momentum but faces a mildly supportive macro backdrop for the sector. Assigning 0.5 — minimal edge to continue down, but not enough to fade it either. The bounded risk profile justifies taking the trade at the threshold.

72. ?Oct 22, 10:05 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.88% today, a modest but meaningful intraday move. No news headlines are present to explain the move, which is common — this likely reflects quiet accumulation or sector rotation into defensive consumer staples. CLX as a consumer staples name is not directly reactive to the elevated 2Y yield environment (4.77, 2.1σ above trend), which is more impactful for banks and long-duration tech. In fact, defensive staples like CLX can attract flows when rates pressure growth sectors, providing mild tailwind. With 340 minutes remaining (essentially the full afternoon session), there is ample time for continuation. The move magnitude (~1.88%) is below the 2-5% high-conviction threshold, so momentum signal is moderate rather than strong. No reversal pattern or fade signal is evident. With bounded risk via a 1.5% stop, a mild lean toward continuation is warranted, but absent a clearer catalyst or volume confirmation, confidence is limited. Probability sits just above neutral.

73. !Oct 22, 10:05 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.88% today, a modest but meaningful intraday move. No news headlines are present to explain the move, which is common — this likely reflects quiet accumulation or sector rotation into defensive consumer staples. CLX as a consumer staples name is not directly reactive to the elevated 2Y yield environment (4.77, 2.1σ above trend), which is more impactful for banks and long-duration tech. In fact, defensive staples like CLX can attract flows when rates pressure growth sectors, providing mild tailwind. With 340 minutes remaining (essentially the full afternoon session), there is ample time for continuation. The move magnitude (~1.88%) is below the 2-5% high-conviction threshold, so momentum signal is moderate rather than strong. No reversal pattern or fade signal is evident. With bounded risk via a 1.5% stop, a mild lean toward continuation is warranted, but absent a clearer catalyst or volume confirmation, confidence is limited. Probability sits just above neutral.

74. ?Oct 21, 3:25 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is down 3.19% with only 20 minutes remaining until the forced close. The extremely limited time remaining is the dominant factor here — even if momentum is real, there is insufficient runway for the -1.5% stop to not be at risk of a mean-reversion snap into EOD, and the +3% target is nearly unreachable in 20 minutes from this setup. No news catalysts are present to sustain the move, and CLX is a defensive consumer staples name (Clorox) that is not directly reactive to the elevated 2Y rate environment flagged in the macro context (that pressure is more relevant to Banks and long-duration Tech). With elevated 2Y rates (4.77, +2.1σ), there is mild fundamental headwind for dividend-paying staples, but this is not a same-day catalyst. The absence of news means we cannot confirm whether this move is institution-driven or a temporary dislocation. With 20 minutes left, late-session reversals are common in this type of move on no-news defensive names, and the risk/reward of chasing downside continuation here is poor. Probability below 0.5 to reflect the time constraint and reversal risk.

75. !Oct 21, 3:25 PMsignalseverity -0.03

    Agent 7 — Day Trader — day_trade_skipped

    CLX is down 3.19% with only 20 minutes remaining until the forced close. The extremely limited time remaining is the dominant factor here — even if momentum is real, there is insufficient runway for the -1.5% stop to not be at risk of a mean-reversion snap into EOD, and the +3% target is nearly unreachable in 20 minutes from this setup. No news catalysts are present to sustain the move, and CLX is a defensive consumer staples name (Clorox) that is not directly reactive to the elevated 2Y rate environment flagged in the macro context (that pressure is more relevant to Banks and long-duration Tech). With elevated 2Y rates (4.77, +2.1σ), there is mild fundamental headwind for dividend-paying staples, but this is not a same-day catalyst. The absence of news means we cannot confirm whether this move is institution-driven or a temporary dislocation. With 20 minutes left, late-session reversals are common in this type of move on no-news defensive names, and the risk/reward of chasing downside continuation here is poor. Probability below 0.5 to reflect the time constraint and reversal risk.

76. ?Oct 19, 10:30 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is down 2.60% today with no attributable headline, suggesting institutional selling or sector rotation rather than a news-driven event. With 315 minutes remaining (roughly 5+ hours of session time), there is ample runway for continuation. The macro backdrop of elevated mortgage rates (7.4%, 3.3σ above trend) is not directly reactive to CLX as a consumer staples/household products name, so macro context is largely neutral here. No reversal signals are evident from the data provided. The move is at the lower bound of the 'meaningful conviction' range (2-3%), so while it qualifies as real flow, it lacks the magnitude that would warrant high-conviction continuation. Absence of news is not disqualifying per the framework. On balance, mild continuation bias — the move has modest momentum but no strong catalyst to sustain a sharp further leg down. Probability sits just above the 0.5 threshold, consistent with an ordinary momentum read without a strong reason to expect immediate reversal.

77. !Oct 19, 10:30 AMsignalseverity -0.03

    Agent 7 — Day Trader — day_trade_skipped

    CLX is down 2.60% today with no attributable headline, suggesting institutional selling or sector rotation rather than a news-driven event. With 315 minutes remaining (roughly 5+ hours of session time), there is ample runway for continuation. The macro backdrop of elevated mortgage rates (7.4%, 3.3σ above trend) is not directly reactive to CLX as a consumer staples/household products name, so macro context is largely neutral here. No reversal signals are evident from the data provided. The move is at the lower bound of the 'meaningful conviction' range (2-3%), so while it qualifies as real flow, it lacks the magnitude that would warrant high-conviction continuation. Absence of news is not disqualifying per the framework. On balance, mild continuation bias — the move has modest momentum but no strong catalyst to sustain a sharp further leg down. Probability sits just above the 0.5 threshold, consistent with an ordinary momentum read without a strong reason to expect immediate reversal.

78. ?Oct 15, 9:35 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CLX is up 1.57% today with no attributable headline, suggesting quiet institutional or sector rotation flow rather than a news-driven spike. The move is modest — below the 2% threshold where momentum tends to be self-reinforcing — so continuation conviction is limited. Macro context shows 5-year forward inflation expectations running 1.6σ above trend, which is mildly negative for rate-sensitive consumer staples names like CLX (higher real rates compress defensive valuations), creating a slight headwind to further upside. However, 370 minutes remaining is ample time for the move to extend if the underlying flow is real. No reversal signals are present, no fade pattern described, and the absence of news does not disqualify the move. On balance, a slight lean toward continuation given time remaining and no active reason to fade, but macro rate pressure and modest move magnitude keep conviction near the floor.

79. !Oct 15, 9:35 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CLX is up 1.57% today with no attributable headline, suggesting quiet institutional or sector rotation flow rather than a news-driven spike. The move is modest — below the 2% threshold where momentum tends to be self-reinforcing — so continuation conviction is limited. Macro context shows 5-year forward inflation expectations running 1.6σ above trend, which is mildly negative for rate-sensitive consumer staples names like CLX (higher real rates compress defensive valuations), creating a slight headwind to further upside. However, 370 minutes remaining is ample time for the move to extend if the underlying flow is real. No reversal signals are present, no fade pattern described, and the absence of news does not disqualify the move. On balance, a slight lean toward continuation given time remaining and no active reason to fade, but macro rate pressure and modest move magnitude keep conviction near the floor.

80. ?Oct 15, 7:00 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

81. !Oct 15, 7:00 AMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

82. ?Oct 15, 7:00 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

83. !Oct 15, 7:00 AMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

84. ?Oct 14, 6:02 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    CLX (Clorox) is a well-established consumer staples company with durable brand equity, and there are no company-specific negative catalysts in the available evidence — no earnings warnings, guidance cuts, or accounting issues are visible in the recent news or SEC filings. However, the macro context is a headwind: the 5-year forward inflation rate is running 1.7σ above its 24-month trend, which pressures rate-sensitive and consumer staples names through higher discount rates and input cost concerns. The 10-K and 8-K filings lack granular metrics, making it difficult to confirm balance sheet health, and the 23.3% drawdown — just shy of the 25% threshold — warrants caution given the elevated inflation expectations backdrop.

85. !Oct 14, 6:02 PMsignalseverity 0.12

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    CLX (Clorox) is a well-established consumer staples company with durable brand equity, and there are no company-specific negative catalysts in the available evidence — no earnings warnings, guidance cuts, or accounting issues are visible in the recent news or SEC filings. However, the macro context is a headwind: the 5-year forward inflation rate is running 1.7σ above its 24-month trend, which pressures rate-sensitive and consumer staples names through higher discount rates and input cost concerns. The 10-K and 8-K filings lack granular metrics, making it difficult to confirm balance sheet health, and the 23.3% drawdown — just shy of the 25% threshold — warrants caution given the elevated inflation expectations backdrop.

86. ?Oct 14, 4:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

87. ?Oct 14, 4:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

88. !Oct 14, 4:20 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

89. !Oct 14, 4:20 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

90. ?Oct 14, 3:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

91. !Oct 14, 3:20 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

92. ?Oct 14, 3:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

93. !Oct 14, 3:20 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

94. ?Oct 14, 2:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

95. ?Oct 14, 2:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

96. !Oct 14, 2:20 PMsignalseverity 0.13

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

97. !Oct 14, 2:20 PMsignalseverity 0.13

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

98. ?Oct 14, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

99. ?Oct 14, 1:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

100. !Oct 14, 1:20 PMsignalseverity 0.12

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

101. !Oct 14, 1:20 PMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

102. ?Oct 14, 12:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

103. !Oct 14, 12:21 PMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

104. ?Oct 14, 12:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

105. !Oct 14, 12:20 PMsignalseverity 0.13

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

106. ?Oct 14, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

107. !Oct 14, 11:20 AMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

108. ?Oct 14, 11:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

109. !Oct 14, 11:20 AMsignalseverity 0.13

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

110. ?Oct 14, 10:21 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

111. ?Oct 14, 10:21 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

112. ?Oct 14, 7:00 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

113. ?Oct 14, 7:00 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

114. ?Oct 13, 6:02 PMdecisionconsidered

     Agent 4 — Dip Buyer (Frozen) — decide: skip

     CLX (Clorox) is a well-established consumer staples company with durable brand equity, and there are no company-specific negative catalysts in the available evidence — no earnings warnings, guidance cuts, or accounting issues are visible in the recent news or SEC filings. However, the macro context is a headwind: the 5-year forward inflation rate is running 1.7σ above its 24-month trend, which pressures rate-sensitive and consumer staples names through higher discount rates and input cost concerns. The 10-K and 8-K filings lack granular metrics, making it difficult to confirm balance sheet health, and the 23.3% drawdown — just shy of the 25% threshold — warrants caution given the elevated inflation expectations backdrop.

115. ?Oct 13, 4:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

116. ?Oct 13, 4:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

117. ?Oct 13, 3:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

118. ?Oct 13, 3:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

119. ?Oct 13, 2:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

120. ?Oct 13, 2:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

121. ?Oct 13, 1:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

122. ?Oct 13, 1:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

123. ?Oct 13, 12:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

124. ?Oct 13, 12:21 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

125. ?Oct 13, 11:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

126. ?Oct 13, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

127. ?Oct 13, 10:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     CLX is down 27% from its 30-day high with no identifiable fundamental deterioration visible in the sparse filings and no negative news headlines. Insider activity on 2026-09-23 was entirely award-based (restricted stock/equity grants), not open-market purchases, so they do not qualify as cluster buys. Options flow is roughly balanced (P/C 0.93, with call z-score of -1.15 indicating below-normal call volume), providing no positive signal. Earnings are 32 days out, applying a meaningful uncertainty headwind (-1). The 10Y at 5.26% is a structural headwind for a consumer staples name trading at these levels (-1). Net signal score is roughly 0 to +1 (sector underperformance +1, large drop magnitude +1, no imminent earnings +1, balanced/negative macro -1, high 10Y -1, earnings in 15-30 days -1), landing near +1 — marginal territory without a compelling cluster buy or unusual call flow to tip the scales.

128. ?Oct 13, 10:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CLX is down 25.2% from its 30-day high, a significant but not anomalous drop for a Consumer Staples name. The sole news headline reflects cautious but not bearish sentiment ("operations should improve, but I'll be patient"), suggesting the drop may be an overreaction or tied to soft near-term results rather than lasting fundamental impairment. The sector is underperforming SPY meaningfully (-3.29pts over 30d), indicating some macro/sector tailwinds are absent, but CLX's fundamental franchise remains intact. Options flow shows slightly elevated put volume (z=1.97) which is a mild negative signal, while call volume is near-normal (z=0.42). No insider buying to confirm the dip, and the 10Y at 5.11% is a structural headwind for dividend-paying staples.

129. ▣Sep 30, 8:00 PMjournalstop

     Agent 5 — Dip Buyer (Evolving) closed long 11 @ $80.79 (-$77.83)

     intraday stop sweep

130. ❖Sep 30, 12:33 PMnewsvia finnhub

     Colgate's Innovation and Premiumization Drive: Can Momentum Persist?

     CL's innovation, premiumization and emerging-market expansion are strengthening its brands and creating avenues for long-term growth.

131. ❖Sep 28, 4:12 PMnewsvia finnhub

     Clorox (CLX) Launches Purell ProCare, Is The Stock Still Cheap?

     Clorox (CLX) has put its latest acquisition to work, launching the Clorox Purell ProCare health and hygiene platform. The new platform combines CloroxPro with GOJO under a unified offering for professional and healthcare customers. For investors, the Clorox Purell ProCare launch lands at a tricky moment. The share price closed at US$83.80, with a 1-day share price return of 2.44% that sits against a 30-day share price decline of 18.27% and a 1-year total shareholder return that is down...

132. ❖Sep 28, 10:00 AMnewsvia finnhub

     The Clorox Company Announces the Official Launch of Clorox Purell ProCare™

     The Clorox Company today announced the launch of Clorox Purell ProCare™, an industry-leading health and hygiene platform combining CloroxPro and GOJO, Makers of Purell, which Clorox acquired earlier this year. Clorox Purell ProCare's unified sales and service organization and network of leading distributors offer professional and healthcare customers convenient access to its broad portfolio of innovative solutions from trusted brands like Clorox, Purell, Pine-Sol, Glad and more.

133. ❖Sep 28, 8:00 AMnewsvia finnhub

     Clorox Just Raised Its Dividend Again. Can Earnings Keep Up?

     Clorox has raised its dividend for decades, but a cratering stock price, a payout ratio management calls elevated, and a debt load that ballooned after two major deals raise a pointed question about whether that streak survives fiscal 2027.

134. ❖Sep 28, 7:30 AMnewsvia finnhub

     Clorox: The 6% Yield & Bargain Valuation Can't Fix A Slow Recovery

135. ❖Sep 27, 8:56 PMnewsvia finnhub

     Best Dividend Aristocrats For October 2026

     The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.

136. ❖Sep 27, 3:32 PMnewsvia finnhub

     You'll Never Guess How Clorox Ended Up Owning Ranch

     You'll Never Guess How Clorox Ended Up Owning Ranch

137. ❖Sep 25, 11:35 PMnewsvia finnhub

     Beyond Revenue Growth: Unpacking The Drivers Of Consumer Products Growth

     Visible Alpha consensus estimates for CY2026 show a wide dispersion in expected growth across the household and personal products peer group.

138. ❖Sep 25, 11:44 AMnewsvia finnhub

     2 Mid-Cap Stocks on Our Watchlist and 1 We Find Risky

     Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

139. ❖Sep 24, 7:44 PMnewsvia finnhub

     Clorox: Operations Should Improve Going Forward, But I'll Be Patient

     Clorox looks more attractive as ERP issues fade; GOJO adds growth and guidance improves. Read here for a detailed investment analysis of CLX stock.

140. ❖Sep 24, 9:00 AMnewsvia finnhub

     HIDDEN VALLEY® INTRODUCES SPOOKY RANCH: THE ICONIC DRESSING TAKES ON A HAUNTING HUE FOR HALLOWEEN

     Halloween is around the corner, and America's #1 Ranch* is ready for the party. Today, Hidden Valley Ranch launched Spooky Ranch, its first-ever seasonal product, giving the Original Ranch fans know and love a daring twist for a limited time.

141. ❖Sep 24, 7:03 AMnewsvia finnhub

     Clorox's Selloff May Not Be Over Yet (Rating Downgrade)

     The Clorox Company is down 21% in a month. It’s rated a Sell: falling organic sales, margin erosion, weak catalysts, and valuation risks. Click for a CLX update.

142. ❖Sep 23, 8:31 PMnewsvia finnhub

     Clorox Declares Regular Quarterly Dividend of $1.25 Per Share

     The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.25 per share on the company's common stock. The dividend is payable November 13, 2026, to shareholders of record as of the close of business on October 28, 2026.

143. ❖Sep 23, 10:49 AMnewsvia finnhub

     The Clorox Company Stock: Is CLX Underperforming the Consumer Staples Sector?

     Clorox has underperformed the consumer staples sector over the past three months. Wall Street analysts are tepid about its prospects.

144. ❖Sep 22, 4:54 AMnewsvia finnhub

     Clorox: The Fundamentals Are Deteriorating - The Dividends Won't Save You

     Clorox (CLX) is downgraded to sell as sales slide, debt nears $4B, and free cash flow can’t cover the 6% dividend.

145. ❖Sep 21, 12:22 PMnewsvia finnhub

     Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?

     PG faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as rising costs, FX pressure and other factors weigh on margins.

146. ❖Sep 21, 9:19 AMnewsvia finnhub

     Clorox vs. Kimberly-Clark: Which Household Staples Dividend Is Safer

     Both Clorox and Kimberly-Clark have raised their dividends for years and offer yields above 5%, but one of them is sitting on a payout that its own management quietly admits may not be sustainable.

147. ❖Sep 19, 10:34 AMnewsvia finnhub

     These 6 Massive Dividend Yields May Be Too Good to Be True

     A fat dividend yield can signal a stock worth buying or a company quietly falling apart, and telling the difference requires looking past the payout itself at the cash flow, debt load, and share price collapse hiding behind the number.

148. ❖Sep 18, 9:44 AMnewsvia finnhub

     3 Consumer Stocks We Keep Off Our Radar

     Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. On the other hand, they usually underperform during bull runs, and this paradigm has rung true over the past six months as the sector was flat while the S&P 500 returned 14%.

149. ❖Sep 17, 11:40 AMnewsvia finnhub

     ADRNY vs. CLX: Which Stock Should Value Investors Buy Now?

     ADRNY vs. CLX: Which Stock Is the Better Value Option?

150. ❖Sep 16, 12:40 PMnewsvia finnhub

     Will Strategic Initiatives and Pricing Strength Boost Clorox's Growth?

     CLX's margin management, innovation and IGNITE strategy support growth, while cost pressures and value-conscious consumers challenge its progress.

151. ❖Sep 15, 5:10 AMnewsvia finnhub

     Is Clorox (CLX) Reasonably Priced on Its Earnings Today?

     Clorox has seen its share price fall sharply over recent years, which puts fresh attention on what investors are really paying for its earnings today. With the stock back near levels that some long term holders may not have expected, the key issue is how well the current price lines up with the profits the business is generating. Over the past 5 years, Clorox shares have declined 35.4%, which raises the question of whether the market has reset expectations to match the company’s earnings...

152. ▢Sep 14, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 11 @ $87.86

153. ▣Jun 11, 8:00 PMjournalstop

     options_momentum closed long 100 @ $3.81 (-$91.10)

     Stop: premium $3.81 ≤ trailing floor $3.84 (peak $5.12 × 0.75)

154. ❖Jun 9, 8:41 AMnewsvia finnhub

     Trading the market downturn: The committee's next move

     The Investment Committee debate how to trade the losses in the NASDAQ. They reveal their next portfolio moves.

155. ▢Jun 8, 8:00 PMjournal

     options_momentum opened long 100 @ $4.72

156. ❖Jun 8, 8:05 AMnewsvia finnhub

     2 S&P 500 Stocks on Our Buy List and 1 We Avoid

     The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

157. ▣Jun 7, 8:00 PMjournalstop

     options_momentum closed long 100 @ $2.82 (-$282.14)

     Stop: premium $2.82 ≤ trailing floor $4.47 (peak $5.96 × 0.75)

158. ❖Jun 7, 5:45 AMnewsvia finnhub

     Clorox: Don't Fall For The Value Trap

     Clorox stock remains a hold as flat revenue, falling organic sales, and weaker margins persist. Read the full analysis here.

159. ❖Jun 7, 1:21 AMnewsvia finnhub

     The Reasons Why I Believe A Buy Rating Is Not Justified For Clorox (Rating Upgrade)

     Clorox (CLX) Q: sales flat, EPS up despite margin pressure from energy costs. Read the full analysis here.

160. ❖Jun 6, 12:24 AMnewsvia finnhub

     Is It Time To Reconsider Clorox (CLX) After A Tough Year For The Stock Price

     This article examines whether Clorox now looks like a bargain or still appears expensive after a difficult stretch for the stock, and walks through what the current price might be implying. Clorox shares last closed at US$94.14. The stock is up 4.6% over the past week and 4.6% over the past month, but is still showing a decline of 6.7% year to date and a decline of 23.0% over the past year. These moves sit against a backdrop of ongoing interest in defensive consumer staples, with market...

161. ❖Jun 5, 4:36 PMnewsvia finnhub

     Stocks Settle Sharply Lower as Tech Companies Routed

     The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -2.64%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -4.77%. June E-mini S&P futures (ESM26 ) fell -2.97%, and June E-mini Nasdaq futures...

162. ❖Jun 5, 3:05 PMnewsvia finnhub

     Stay informed with the top movers within the S&P500 index on Friday.

     Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

163. ❖Jun 5, 12:58 PMnewsvia finnhub

     CNBC Markets Now: June 5, 2026

     CNBC Markets Now provides a look at the day's market moves with commentary and analysis from Michael Santoli, CNBC Senior Markets Commentator.

164. ❖Jun 5, 12:35 PMnewsvia finnhub

     Which S&P500 stocks are moving on Friday?

     Stay updated with the movements of the S&P500 index in the middle of the day on Friday. Discover which stocks are leading as top gainers and losers in today's session.

165. ❖Jun 5, 9:25 AMnewsvia finnhub

     Investors are taking profits ahead of SpaceX IPO, says Capital Wealth's Kevin Simpson

     The CNBC Halftime Report Investing Committee discusses the latest moves in the market after the May jobs report and a sell-off in tech stocks.

166. ❖Jun 4, 5:01 PMnewsvia finnhub

     1 Oversold Stock Ready to Bounce Back and 2 We Find Risky

     Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

167. ❖Jun 3, 4:52 AMnewsvia finnhub

     The Clorox Company (CLX) Presents at 23rd annual dbAccess Global Consumer Conference Transcript

     The Clorox Company (CLX) 23rd annual dbAccess Global Consumer Conference June 3, 2026 6:00 AM EDTCompany ParticipantsLuc Bellet - Executive VP &...

168. ❖Jun 3, 4:40 AMnewsvia finnhub

     Buy 4 S&P 500 Best June Dividend Dogs

     Four S&P 500 stocks offer high yields, strong free cash flow, and are currently buyable under the 'safer' dividend dog criteria. Read the full analysis now.

169. ❖Jun 2, 9:00 AMnewsvia finnhub

     Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges

     Clorox Healthcare today announced two new innovative products designed to address critical challenges in infection prevention: Clorox Healthcare Quat Alcohol Disinfecting Wipes and Clorox Healthcare HyperOxi Disinfecting Wipes. These new wipes are designed to address critical needs in healthcare environments, helping improve workflow efficiency and compliance.

170. ▣May 28, 8:00 PMjournalstop

     options_momentum closed long 100 @ $2.93 (-$298.08)

     Stop: premium $2.93 ≤ trailing floor $4.95 (peak $6.60 × 0.75)

171. ▢May 28, 8:00 PMjournal

     options_momentum opened long 100 @ $5.64

172. ▢May 21, 8:00 PMjournal

     options_momentum opened long 100 @ $5.91

173. ▣May 18, 8:00 PMjournalbank_funding

     Agent 5 — Dip Buyer (Evolving) closed long 19 @ $93.65 (+$60.80)

     Backfill 2026-05-19: closed at current mark to fund initial BANK sweep (highest unrealized P&L first; brings working equity to starting capital).

174. ▢May 17, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 19 @ $90.45